Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Change in Account Payables (2021 - 2025)

Rxo's Change in Account Payables history spans 5 years, with the latest figure at $58.0 million for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 422.22% year-over-year to $58.0 million; the TTM value through Dec 2025 reached -$16.0 million, up 75.38%, while the annual FY2025 figure was -$16.0 million, 75.38% up from the prior year.
  • Change in Account Payables reached $58.0 million in Q4 2025 per RXO's latest filing, up from $19.0 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $216.0 million in Q1 2022 to a low of -$121.0 million in Q2 2022.
  • Average Change in Account Payables over 5 years is -$4.8 million, with a median of -$20.0 million recorded in 2024.
  • The largest YoY upside for Change in Account Payables was 422.22% in 2025 against a maximum downside of 364.29% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at $99.0 million in 2021, then plummeted by 139.39% to -$39.0 million in 2022, then grew by 23.08% to -$30.0 million in 2023, then soared by 40.0% to -$18.0 million in 2024, then soared by 422.22% to $58.0 million in 2025.
  • Per Business Quant, the three most recent readings for RXO's Change in Account Payables are $58.0 million (Q4 2025), $19.0 million (Q3 2025), and -$37.0 million (Q2 2025).